Shane Watson's new book, protein powder revelations, the story behind Forest Essentials are some stories that piqued the interest of our readers this week
1. Big strides
In the world of big pharma, Vasant ‘Vas’ Narasimhan is most certainly an exception. The son of Indian immigrants and a doctor by training, Narasimhan is the only CEO of Indian origin among the world’s top 20 pharmaceutical companies by revenue. But, more importantly, Narasimhan is also the only one among his compatriots who comes from a R&D background in the sector. That’s precisely why, since he took charge of the $210 billion Switzerland-based Novartis seven years ago, Narasimhan has pivoted the company from a diversified conglomerate with interests in eye-wear, generic medicines, and consumer medicines into a pure-play innovative medicines company. Here’s how he’s transforming the company and readying India to play a bigger role in its medicine pipeline.
2. A ready reckoner